Start | End | Session | Speaker |
---|---|---|---|
9:30 am, CT | 10:00 am | Exhibitor Session | |
10:00 am | 11:00 am |
Welcome
|
Nicole Bell, LMSW Julie Larson, LCSW |
11:00 am | 11:15 am | Break with Exhibitors | |
11:15 am | 12:15 am | Concurrent Breakout Sessions | |
Myelodysplastic Syndromes (MDS) | Muthu Veeraputhiran, MD Winthrop P. Rockefeller Cancer Institute University of Arkansas for Medical Sciences |
||
Adult Acute Myeloid Leukemia (AML) | Prapti Patel, MD UT Southwestern Medical Center Simmons Comprehensive Cancer Center |
||
Lymphoma High Grade |
Farrukh Awan, MD UT Southwestern Medical Center |
||
Chronic Lymphocytic Leukemia (CLL) | William Matsui, MD LIVESTRONG Cancer Institutes University of Texas at Austin |
||
Adult Acute Lymphoblastic Leukemia (ALL) | Matthew Wieduwilt, MD, PhD Oklahoma University College of Medicine Stephenson Cancer Center |
||
Immunosuppression During Treatment: Risks and Prevention | Estil Vance, MD Texas Oncology-Medical City Dallas Blood and Marrow Transplant |
||
Survivorship Issues: Strategies for Successful Coping |
Harold Dean, MSW, LCSW, OSW-C Myeloma Institute University of Arkansas for Medical Sciences
April Dumond, MSN, RN, OCN |
||
12:15 am | 12:30 pm | Break with Exhibitors | |
12:30 pm | 1:30 pm | Concurrent Breakout Sessions | |
Chronic Myeloid Leukemia (CML) | Yazan Madanat, MD UT Southwestern Medical Center Simmons Comprehensive Cancer Center |
||
Lymphoma Low Grade |
Robert Brian Berryman, MD Baylor University Medical Center & Texas Oncology |
||
Multiple Myeloma |
Larry Anderson, MD, PhD |
||
Myeloproliferative Neoplasms (MPN) |
Harris Naina, MD, FACP Texas Oncology Fort Worth Cancer Center |
||
Hodgkin Lymphoma |
Sairah Ahmed, MD The University of Texas |
||
Immunosuppression During Treatment: Risks and Prevention | Estil Vance, MD Texas Oncology-Medical City Dallas Blood and Marrow Transplant |
||
Survivorship Issues: Strategies for Successful Coping |
Harold Dean, MSW, LCSW, OSW-C Myeloma Institute University of Arkansas for Medical Sciences
April Dumond, MSN, RN, OCN |
||
1:30 pm | Complete Evaluations & Conference Concludes |